loader
Please Wait
Applying Filters...
menu
    • menu

    Looking for Oral Finished Formulations containing METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1)? Find Methacrylic Acid Methyl Methacrylate Copolymer 1:1 based pharmaceutical excipients on PharmaCompass.

    Client Email Product
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    Menu

    Methacrylic Acid Methyl Methacrylate Copolymer 1:1

    INACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    EXCIPIENTS BY APPLICATIONS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 1ACAMPROSATE CALCIUM

    02 1ACETAZOLAMIDE

    03 1ADDERALL XR 10

    04 1ADDERALL XR 15

    05 1ADDERALL XR 20

    06 1ADDERALL XR 25

    07 1ADDERALL XR 30

    08 1ADDERALL XR 5

    09 1AGGRENOX

    10 1ANAPROX

    11 1ANAPROX DS

    12 1APRISO

    13 1ARTHROTEC

    14 1ASACOL HD

    15 1ASPIRIN AND DIPYRIDAMOLE

    16 1BUDESONIDE

    17 1BUPROPION HYDROCHLORIDE

    18 1CARVEDILOL PHOSPHATE

    19 1DEXILANT

    20 6DEXMETHYLPHENIDATE HYDROCHLORIDE

    21 1DICLOFENAC SODIUM

    22 2DILTIAZEM HYDROCHLORIDE

    23 3DIMETHYL FUMARATE

    24 1DIVALPROEX SODIUM

    25 1DONEPEZIL HYDROCHLORIDE

    26 1EC-NAPROSYN

    27 1FOCALIN XR

    28 2GLIPIZIDE

    29 1INDOMETHACIN

    30 1JALYN

    31 1KADIAN

    32 2LANSOPRAZOLE

    33 1LIALDA

    34 1MESALAMINE

    35 1METFORMIN HYDROCHLORIDE

    36 1MOXATAG

    37 1NAPROSYN

    38 1NEXIUM 24HR

    39 1NIFEDIPINE

    40 2OMEPRAZOLE

    41 1OMEPRAZOLE MAGNESIUM

    42 2PANTOPRAZOLE SODIUM

    43 1PREVACID 24 HR

    44 1RANOLAZINE

    45 1RYTARY

    46 1TAMSULOSIN HYDROCHLORIDE

    47 1VERAPAMIL HYDROCHLORIDE

    48 1WELLBUTRIN XL

    49 1ZOLPIDEM TARTRATE

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    Left Arrow
    Right Arrow
    ListList of Suppliers

    01

    ABBVIE
    U.S.A
    arrow
    FNCE 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    MESALAMINE

    Drug : ASACOL HD

    Dosage Form : TABLET, DELAYED RELEASE; ORAL

    Application Number : 21830

    Country : US

    Patented : No

    Abbvie Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    ALLERGAN
    U.S.A
    arrow
    FNCE 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    MORPHINE SULFATE

    Drug : KADIAN

    Dosage Form : CAPSULE, EXTENDED RELEASE; ORAL

    Application Number : 20616

    Country : US

    Patented : No

    Abbvie CB

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    ATNAHS PHARMA US

    NAPROXEN SODIUM

    arrow
    FNCE 2024
    Not Confirmed
    ATNAHS PHARMA US
    United Kingdom
    arrow
    FNCE 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    NAPROXEN SODIUM

    Drug : ANAPROX DS

    Dosage Form : TABLET; ORAL

    Application Number : 18164

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    ATNAHS PHARMA US

    NAPROXEN SODIUM

    arrow
    FNCE 2024
    Not Confirmed
    ATNAHS PHARMA US
    United Kingdom
    arrow
    FNCE 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    NAPROXEN SODIUM

    Drug : ANAPROX

    Dosage Form : TABLET; ORAL

    Application Number : 18164

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    ATNAHS PHARMA US

    NAPROXEN

    arrow
    FNCE 2024
    Not Confirmed
    ATNAHS PHARMA US
    United Kingdom
    arrow
    FNCE 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    NAPROXEN

    Drug : NAPROSYN

    Dosage Form : TABLET; ORAL

    Application Number : 17581

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    GLENMARK PHARMS LTD

    DIMETHYL FUMARATE

    arrow
    FNCE 2024
    Not Confirmed
    GLENMARK PHARMS LTD
    India
    arrow
    FNCE 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    DIMETHYL FUMARATE

    Drug : DIMETHYL FUMARATE

    Dosage Form : CAPSULE, DELAYED RELEASE; ORAL

    Application Number : 210309

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    GLENMARK PHARMS INC

    LANSOPRAZOLE

    arrow
    FNCE 2024
    Not Confirmed
    GLENMARK PHARMS INC
    India
    arrow
    FNCE 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    LANSOPRAZOLE

    Drug : LANSOPRAZOLE

    Dosage Form : CAPSULE, DELAYED REL PELLETS; ORAL

    Application Number : 202727

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    ENDO OPERATIONS

    DONEPEZIL HYDROCHLORIDE

    arrow
    FNCE 2024
    Not Confirmed
    ENDO OPERATIONS
    Country
    arrow
    FNCE 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    DONEPEZIL HYDROCHLORIDE

    Drug : DONEPEZIL HYDROCHLORIDE

    Dosage Form : TABLET; ORAL

    Application Number : 202542

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    RISING PHARMA

    VERAPAMIL HYDROCHLORIDE

    arrow
    FNCE 2024
    Not Confirmed
    RISING PHARMA
    Country
    arrow
    FNCE 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    VERAPAMIL HYDROCHLORIDE

    Drug : VERAPAMIL HYDROCHLORIDE

    Dosage Form : CAPSULE, EXTENDED RELEASE; ORAL

    Application Number : 78306

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    ENDO OPERATIONS

    DILTIAZEM HYDROCHLORIDE

    arrow
    FNCE 2024
    Not Confirmed
    ENDO OPERATIONS
    Country
    arrow
    FNCE 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    DILTIAZEM HYDROCHLORIDE

    Drug : DILTIAZEM HYDROCHLORIDE

    Dosage Form : CAPSULE, EXTENDED RELEASE; ORAL

    Application Number : 74984

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF